Last reviewed · How we verify
NCT07260903
Can Photobiomodulation Improve Balance and Cognition in Individuals Over 60: a Pilot Feasibility Placebo Randomized Controlled Trial.
NA trial testing Photobiomodulation in Age >60 in 60 participants. Currently enrolling.
1 May 2027
Quick facts
| Lead sponsor | University of Central Lancashire |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 June 2025 |
| Primary completion | 1 May 2027 |
| Estimated completion | 10 July 2027 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Photobiomodulation
- Sham 8-weeks photobiomodulation
Conditions studied
- Age >60 — all drugs for Age >60 →
Sponsor
University of Central Lancashire
Who can join
Adults 60 to 80, any sex, with Age >60. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
As people age, changes in balance and memory can make daily life more difficult and increase the risk of falls. Falls are one of the main causes of injury, hospitalization and loss of independence in older adults, while even mild declines in memory and concentration can reduce confidence, social participation and overall quality of life. Therefore, safe, affordable, and practical ways to help older adults remain steady on their feet and mentally sharp are urgently needed. The aim of this project is therefore to conduct a pilot feasibility randomized controlled trial to examine whether regular home-based photobiomodulation can improve balance and cognitive function in adults aged over 60. If successful, this research could help shape future strategies for preventing falls, enhancing wellbeing and maintaining independence in older people.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07260903
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Photobiomodulation
Trials testing the same drug.
- NCT07296068 — Can Acute Photobiomodulation Improve Balance and Cognition in Individuals With Ataxia: a Pilot Feasibility Placebo Rando · NA · not yet recruiting
- NCT07183267 — Using Red Light Therapy to Ease Skin Side Effects and Mouth Side Effects, in Children and Young People Aged 0 to 16 Year · NA · not yet recruiting
- NCT07476209 — Sialendoscopy Versus Photobiomodulation in Prevention of Radiation Induced Xerostomia · NA · recruiting
- NCT06984796 — Photobiomodulation on Pain Perception During the Insertion of the T 380 Copper Intrauterine Device (IUD) · NA · not yet recruiting
- NCT07425080 — HELIOS Advanced: Human Oocyte Illumination to Enhance Development · NA · recruiting
Other University of Central Lancashire trials
Trials by the same sponsor.
- NCT07350473 — Effects of Vibration-Assisted Physical Activity in Type-2 Diabetes · NA · not yet recruiting
- NCT07296068 — Can Acute Photobiomodulation Improve Balance and Cognition in Individuals With Ataxia: a Pilot Feasibility Placebo Rando · NA · not yet recruiting
- NCT06901986 — Health Benefits of Tart Cherry in Crohn's Disease · NA · not yet recruiting
- NCT06559982 — Effects of a Brown Seaweed Tart Cherry Blend in Mild-moderate Hypertension · NA · not yet recruiting
- NCT06795438 — Effects of Green Tea on Cardiometabolic Outcomes · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07260903 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Central Lancashire
- Last refreshed: 3 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07260903.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing